Consolidated Financial Statements Details - Intangible Assets, Net (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Intangible assets, net | |||
Cost | $ 15,247 | $ 15,247 | $ 15,247 |
Accumulated Amortization | 994 | 994 | 97 |
Impairment Charge | 14,253 | ||
Net Carrying Value | 15,150 | ||
Ebopiprant IP | |||
Intangible assets, net | |||
Cost | 15,247 | 15,247 | 15,247 |
Accumulated Amortization | 994 | 994 | 97 |
Impairment Charge | $ 14,253 | ||
Net Carrying Value | 15,150 | ||
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income | Impairment charges (Note 4, Note 5) | ||
Ebopiprant IP | ObsEva, Organon | License Agreement | |||
Intangible assets, net | |||
Impairment Charge | $ 14,200 | $ 14,200 | $ 0 |
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income | Impairment charges (Note 4, Note 5) | Impairment charges (Note 4, Note 5) |
X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Indicates line item in statement of income or comprehensive income that includes impairment of finite-lived intangible asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|